Overview

InvestingPro’s AI‑driven stock‑picker article dated 25 August 2026 highlights a suite of high‑conviction value equities that have delivered outsized returns since being flagged by the model. The piece serves both as a performance showcase and a subscription promotion for the InvestingPro service, which costs less than $8 per month during a summer‑sale discount of up to 55%.

August Stock Performance

The AI‑selected portfolio generated remarkable month‑over‑month gains in August. Haemonetics Corp (NYSE:HAE) rose +26.72% in August and +98.75% since it was first picked, while TPG Inc (NASDAQGS:TPG) posted +22.34% in August and +30.47% since selection. Merck & Co (NYSE:MRK) added +15.71% in August and +45.23% since pick. Everforth (NYSE:EFOR) climbed +14.28% in August (+85.08% since pick) and SM Energy (NYSE:SM) rose +12.12% in August (+41.70% since pick). Additional global winners included Yubico AB (OM:YUBICO) with +40.98% in August (+109.58% since pick), Indosat (IDX:ISAT) +38.42% in August (+46.52% since pick), Regional Container (SET:RCL) +30.74% in August (+43.65% since pick), GS Holdings (KOSE:A078930) +28.76% in August (+56.56% since pick), and Atp Ticari Bilgisayar Ağı ve Elektrik (IBSE:ATATP) +26.69% in August (+113.43% since pick). Earlier‑month highlights for U.S. equities included Mativ Holdings (NYSE:MATV) +40.32%, Ramaco Resources (NASDAQGS:METC) +35.55%, and Gartner (NYSE:IT) +34.27% during August alone.

Spotlight: Haemonetics Corp

Identified by the model in September 2025, Haemonetics has delivered a near‑doubling of its share price over the past 12 months. The company reported $339.4 million of revenue and $1.14 earnings per share (EPS) for Q1 2027, and management lifted its full‑year revenue growth outlook to a 5%‑8% range. Valuation metrics show the stock trading at 56% of its 52‑week high, with a forward price‑to‑earnings (P/E) multiple of 14.9x and a 0.34 price‑to‑earnings‑growth (PEG) ratio. Profitability remains strong, with a 58.8% gross margin and a 19.4% operating margin, while EBITDA surged 23.6% year‑over‑year. A Citi upgrade to “Buy” with a $90 price target reinforces institutional confidence, compared with consensus fair‑value estimates around $78.

Spotlight: Merck & Co

First flagged in January 2026, Merck & Co has posted a +45.23% rally over seven months. The firm generated $16.61 billion of revenue and $2.28 EPS in the most recent quarter, prompting management to raise full‑year revenue guidance to $67.3 billion. The stock trades at a modest 13.9x earnings multiple and a low 0.24 PEG ratio, reflecting a deep valuation discount. Recent earnings showed Q3 EPS of $2.58, beating forecasts by roughly 10%, and EBITDA grew 56.3% year‑over‑year. Merck’s pipeline includes 80 Phase III trials and a strategic $9.2 billion acquisition of Cidara Therapeutics, providing a growth moat beyond the flagship Keytruda oncology franchise. Shareholder returns are bolstered by a 3.2% dividend yield and a 10.4% dividend‑growth rate.

Other Notable Picks

The August list also featured strong performers across sectors: Mativ Holdings (+40.32% Aug), Ramaco Resources (+35.55% Aug), Gartner (+34.27% Aug), Yubico AB (+40.98% Aug, +109.58% since pick), Indosat (+38.42% Aug, +46.52% since pick), Regional Container (+30.74% Aug, +43.65% since pick), GS Holdings (+28.76% Aug, +56.56% since pick), and Atp Ticari Bilgisayar (+26.69% Aug, +113.43% since pick).

AI Model Track Record

Since its official launch in November 2023, the InvestingPro AI engine has delivered a cumulative +184.93% return, outperforming the S&P 500 by +104.28% over the same period. These figures are presented as recorded performance, not projected future results.

Methodology

Each month the proprietary AI system scans thousands of global equities, leveraging over 15 years of historical financial data and more than 150 quantitative models. Up to 20 high‑conviction stocks are selected per strategy based on a blend of momentum, valuation, and forward‑looking growth signals. Selections are equally weighted, and the portfolio is rebalanced monthly: new opportunities are added, strong performers are retained, and stocks that no longer meet criteria are removed.

Subscription Offer

The article promotes a summer‑sale subscription for InvestingPro members at less than $8 per month, representing up to 55% discount. Both app and web users are invited to subscribe via provided links.

Disclaimer

Subscription prices are accurate at the time of publication and may vary by region. The performance data reflects historical results and does not guarantee future outcomes.